SAB Biotherapeutics Inc. (SABSW)
0.03
-0.00 (-3.23%)
At close: Feb 28, 2025, 3:59 PM
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $2.24M, reflecting a -90.63% growth. For the quarter ending September 30, 2024, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
$2.24M
Revenue Growth
-90.63%
Price / Sales Ratio
16.97
Revenue / Employee
$39.28K
Employees
57
Market Cap
286.11K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 2.24M | -90.63% |
| 2022-12-31 | 23.9M | -60.73% |
| 2021-12-31 | 60.88M | +10.21% |
| 2020-12-31 | 55.24M | n/a |